Progenics Pharmaceuticals, Inc.

Form 483

New York, New York, United StatesFEI 3013080312Issued September 11, 2017

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3013080312.

Observations1

Issue DateSeptember 11, 2017

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Progenics Pharmaceuticals, Inc.
Location: New York, New York, United States
FEI Number: 3013080312
Product Type: Drugs
Issue Date: September 11, 2017
Country: United States

Inspection History, 2017 to 2021

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Progenics Pharmaceuticals, Inc. FDA Form 483, New York, New York, September 11, 2017